Delayed minocycline but not delayed mild hypothermia protects against embolic stroke

[1]  S. Paul,et al.  Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Paul,et al.  Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons , 2001, Neuroscience Letters.

[3]  C. Wang,et al.  A focal embolic model of cerebral ischemia in rats: introduction and evaluation. , 2001, Brain research. Brain research protocols.

[4]  B. Fiebich,et al.  Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.

[5]  K. Todd,et al.  Patency of Cerebral Microvessels after Focal Embolic Stroke in the Rat , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  G K Steinberg,et al.  Delayed induction and long-term effects of mild hypothermia in a focal model of transient cerebral ischemia: neurological outcome and infarct size. , 2001, Journal of neurosurgery.

[7]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  RobertSchmid-Elsaesser,et al.  Combination Drug Therapy and Mild Hypothermia , 1999 .

[9]  H. Reulen,et al.  Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia. , 1999, Stroke.

[10]  R. Busto,et al.  Postischemic Hypothermia and IL-10 Treatment Provide Long-Lasting Neuroprotection of CA1 Hippocampus Following Transient Global Ischemia in Rats , 1999, Experimental Neurology.

[11]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Shuaib,et al.  Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method , 1998, Journal of Neuroscience Methods.

[13]  G. Steinberg,et al.  Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. , 1998, Stroke.

[14]  F. Barone,et al.  The Role of Cytokines in the Neuropathology of Stroke and Neurotrauma , 1998, Neuroimmunomodulation.

[15]  K. Becker.  Inflammation and acute stroke. , 1998, Current opinion in neurology.

[16]  D. Corbett,et al.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment. , 1997, Molecular neurobiology.

[17]  CiceroCoimbra,et al.  Long-lasting Neuroprotective Effect of Postischemic Hypothermia and Treatment With an Anti-inflammatory/Antipyretic Drug , 1996 .

[18]  T. Wieloch,et al.  Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic processes following ischemia. , 1996, Stroke.

[19]  A. Shuaib,et al.  CGS-19755 is neuroprotective during repetitive ischemia: This effect is significantly enhanced when combined with hypothermia , 1993, Neuroscience.

[20]  A. Shuaib,et al.  During Repetitive Forebrain Ischemia, Post-ischemic Hypothermia Protects Neurons from Damage , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[21]  R. A. Solomon,et al.  Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study. , 1992, Journal of neurosurgery.

[22]  L. Ng,et al.  Massive Cerebral Infarction with Severe Brain Swelling: A CLINICOPATHOLOGICAL STUDY , 1970, Stroke.